in an ongoing cooperative study of the cancer and acute leukemia group b , 21 evaluable patients with advanced malignant lymphomas were treated with 70 mg/m2 of cis-dichlorodiammineplatinum ( ii ) ( cis-platinum ) once every 3 weeks .
C0006826
cancer
C0024299
malignant lymphomas